Fermer le menu

Member of Lyonbiopole


Meddenovo Drug Design builds innovative molecular modelling technologies to create new drug candidates. We ensure that every project is carefully tailored, meticulously eliminating false positive candidates to guarantee a smooth path for further drug development. In addition to our ongoing pipeline, we partner with companies that have struggled to find tools capable of modelling their unconventional drug candidates or the unusual targets they have identified.

Through its proprietary software bioAIM and focAlyze, Meddenovo harnesses the power of physics- and machine learning-based approaches, into an innovative platform to solve complex problems with new mechanisms of actions.


Type of activity: CRO - Tools - R&D platform, Therapeutics, Pharma or Biotech

Created on oct. 23rd, 2023 - 4 employees



13 avenue Albert Einstein 69100 Villeurbanne



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.